Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1992-1-6
|
pubmed:abstractText |
We report 2 studies evaluating the effects of a complete and progressive neuroleptic withdrawal on the symptomatology of 2 groups of 10 young chronically ill schizophrenic inpatients. In a preliminary open study, we compare the psychiatric symptomatology during a 4-week-period before the beginning of withdrawal and during a similar period following the end of withdrawal. We observe the significative improvement of the blunted affect, the deterioration of an aspecific psychiatric symptomatology (including irritability, excitement, hostility) and the non-modification of the specific schizophrenic symptomatology (in its 3 main components: positive signs, negative signs, disorganization). The second study (a double blind one) reports the effects of a complete neuroleptic withdrawal maintained during a longer period (8 weeks): 1. The improvement of the blunted affect is transiently observed during the 2 first weeks after the end of withdrawal but not after this time. 2. The deterioration of the aspecific psychiatric symptomatology by opposition to the non-significative modification of the specific schizophrenic symptomatology is a fact confirmed by this second study. Even if we can not exclude that the influence of neuroleptic withdrawal on the specific psychotic symptoms may require a longer time frame than 8 weeks to detect, this dichotomic evolution raises the problem of the specific action of neuroleptics in this particular category of patients.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0013-7006
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
255-61
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1683626-Adult,
pubmed-meshheading:1683626-Antipsychotic Agents,
pubmed-meshheading:1683626-Female,
pubmed-meshheading:1683626-Humans,
pubmed-meshheading:1683626-Male,
pubmed-meshheading:1683626-Psychiatric Status Rating Scales,
pubmed-meshheading:1683626-Schizophrenia,
pubmed-meshheading:1683626-Schizophrenic Psychology,
pubmed-meshheading:1683626-Substance Withdrawal Syndrome,
pubmed-meshheading:1683626-Time Factors
|
pubmed:articleTitle |
[Complete neuroleptic withdrawal in patients with schizophrenia with intense symptoms and resistant to treatment].
|
pubmed:affiliation |
Centre de recherche Université Laval Robert-Giffard, Beauport, (Québec), Canada.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Case Reports
|